Society Info

The future of AVLS is built upon the same mission that has guided the Society for more than four decades: advancing education, advocacy, and research in venous and lymphatic medicine while supporting the healthcare professionals dedicated to improving patient care.

As we move forward, we are focused on strengthening the programs, relationships, and resources that members value most while exploring new opportunities to serve our specialty.

Education has always been at the heart of AVLS.

Beginning in 2026, AVLS will again offer digital educational programming, webinars, and continuing medical education opportunities designed to support physicians and allied health professionals involved in venous and lymphatic care.

We are also exploring collaborative educational opportunities with other respected medical organizations. These partnerships allow us not only to share resources, but also to expand awareness of venous and lymphatic disease among healthcare professionals who encounter these patients every day.

As educational programs evolve, we want to hear directly from our members. What topics are most important? Which educational formats provide the greatest value? Are there organizations or specialties that would benefit from greater collaboration with AVLS?

The future of our educational programs will be strengthened by member participation and feedback.

AVLS remains committed to representing the interests of healthcare professionals caring for patients with venous and lymphatic disease.

The Society continues to maintain important relationships within organized medicine and remains actively engaged in advocacy efforts that support patient access to care, fair reimbursement, and recognition of our specialty.

Our volunteers and leaders continue to contribute their expertise through national committees, professional organizations, and collaborative initiatives that influence healthcare policy and practice.

Advocacy remains one of the Society's most important responsibilities, and AVLS is committed to maintaining a strong and respected voice on behalf of its members and patients.

Research is essential to advancing the understanding and treatment of venous and lymphatic disease.

The AVLS Patient Reported Outcome (PRO) Venous Registry remains one of the most significant data resources in our field, containing more than 600,000 patient records contributed by nearly 200 practices. This important asset has been preserved and will continue to inform future research efforts.

As AVLS evaluates the next phase of its research initiatives, we remain committed to supporting scientific inquiry, encouraging collaboration, and creating opportunities for members to share their work through abstracts, publications, and research partnerships.

The future of AVLS will be shaped by the dedication, expertise, and engagement of its members.

Our history demonstrates what can be accomplished when professionals unite around a shared purpose. Today, we are building upon that foundation with renewed focus, stronger accountability, and a commitment to serving the needs of our members and patients.

We invite you to join us as we continue advancing venous and lymphatic medicine together.